3-(2-aminoethyl)-indole-2-carboxylic acid ethyl ester | 120876-27-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(2-aminoethyl)-indole-2-carboxylic acid ethyl ester
• 英文别名: 3-(2-amino-ethyl)-indole-2-carboxylic acid ethyl ester；Ethyl 3-(2-aminoethyl)-1H-indole-2-carboxylate
• CAS: 120876-27-9
• 化学式: C₁₃H₁₆N₂O₂
• 分子量: 232.282
• InChiKey: GJJYQBVSOPSDHC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  68.1
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 3-(2-aminoethyl)-indole-2-carboxylic acid ethyl ester 在 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 、 水 为溶剂， 反应 2.0h， 以36%的产率得到3-(2-Dimethylamino-ethyl)-1H-indole-2-carboxylic acid ethyl ester
  参考文献：
  名称：

  N-Arylsulfonylindole Derivatives as Serotonin 5-HT₆ Receptor Ligands

  摘要：

  A series of N-1-arylsulfonyltryptamines were found to be potent ligands of the human serotonin 5-HT6 receptor with the 5-methoxy-1-benzenesulfonyl analogue (19) having the highest affinity. Additionally, it was discovered that a group such as 3-(3-methoxybenzyl)-1,2,4-oxadiazol-5-yI in the 2-position of the indole ring (43) can replace the arylsulfonyl substituent in the 1-position with no loss of affinity. This suggested that the binding conformation of the aminoethyl side chain at this receptor was toward the 4-position of the indole ring and was supported by the fact that the 4-(aminoethyl)indoles (45) also displayed high affinity, as did the conformationally rigid 1,3,4,5-tetrahydrobenz[c,d]indole (49). Molecular modeling showed that 19, 43, and 45 all had low-energy conformers that overlaid well onto 49. Both 19 and 49 had good selectivity over other serotonin receptors tested, with 49 also showing excellent selectivity over all dopamine receptors. In a functional adenylate cyclase stimulation assay, 19 and 49 had no agonist activity, whereas 45 behaved as a partial agonist. Finally, it was shown that 19 had good activity in the 5-HT2A centrally mediated mescaline-induced head twitch assay, which implies that it is brain-penetrant.

  DOI：

  10.1021/jm010943m

文献信息

• Hydroxamate-Based Inhibitors of Deacetylases
  申请人：CHO Young Shin

  公开号：US20110053925A1

  公开（公告）日：2011-03-03

  The present teachings relate to compounds of Formula I: and pharmaceutically acceptable salts, hydrates, esters, and prodrugs thereof, wherein R 1 , R 2 , R 3 , ring A, and are as defined herein. The present teachings also provide methods of preparing compounds of Formula I and methods of using compounds of Formula I in treating, inhibiting, or preventing pathologic conditions or disorders mediated wholly or in part by deacetylases.

  本教导涉及到Formula I的化合物，以及其药用盐、水合物、酯和前药，其中R1、R2、R3、环A和如此定义。本教导还提供了制备Formula I化合物的方法，以及利用Formula I化合物治疗、抑制或预防完全或部分由去乙酰酶介导的病理状况或紊乱的方法。
• 一种β-咔啉类化合物的制备方法
  申请人：南京工业大学

  公开号：CN115093410A

  公开（公告）日：2022-09-23

  本发明公开了一种β‑咔啉类化合物的制备方法，属于有机化学合成技术领域。该β‑咔啉类化合物是具有式Ⅲ所示的化合物。本发明在氧气氛围下，能够通过色胺和醛在离子对盐催化三苯碳四(五氟苯基)硼酸盐(Ph3C+[B(C6F5)4]‑)的条件下一步制得式Ⅲ所示的β‑咔啉类化合物。本发明提供β‑咔啉类化合物的新合成路线具有新颖、高效、原子经济性高、反应条件温和和底物适用范围广等优点，在天然产物活性物质或者小分子药物分子合成领域具有潜在的应用前景。本发明制备方法中所需的催化剂为非金属类型的催化剂，与现有的金属催化的合成方法相比，合成过程更易于纯化，不存在金属残留的问题。作为医药中间体，不存在金属残留导致的生物毒性。
• TETRAHYDRO-PYRAZINO[1,2-A]INDOLES FOR THE TREATMENT OF CENTRAL NERVOUS DISORDERS
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1370561A2

  公开（公告）日：2003-12-17
• US9988377B2
  申请人：——

  公开号：US9988377B2

  公开（公告）日：2018-06-05
• [EN] PIPERAZINE DERIVATIVES<br/>[FR] DERIVES DE LA PIPERAZINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2002072584A2

  公开（公告）日：2002-09-19

  The present invention refers to chemical compounds of formula (I) as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R7 have the significance given in the description and the claims. The compounds can be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, type II diabetes, obesity and sleep apnoea.